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Abstract: 
The present research work deals with synthesize a series of various substituted benzothiazole containing 6-amino- 4-
(substituted aryl)-tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic by reacting 2-mercaptobenzothiazole with hydrazine 
hydrate to synthesize hydrazine derivatives of benzothiazole (1), which then reacted with β- keto ester to develop pyrazole 
derivative (2), and then finally reacted with malononitrile and different aromatic aldehydes to obtain the final compounds 
(3a-3f). The structures of the intermediates and final compounds are assigned by using FTIR and 
1
H-NMR. The final 
compounds were screened for their antibacterial activity against four tested bacteria as G
+ 
and G
-
using a well diffusion 
method. The results of antibacterial activity exhibited that the species Klebsiella pneumonia was the most effected types, 
while Pseudomonas aeruginosa was least the effected in general. 
Keywords:  2-mercaptobenzothiazole; pyranopyrazole; malononitrile; antibacterial. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Council for Innovative Research 
Peer Review Research Publishing System 
Journal: Journal of Advances in Chemistry 
Vol 11, No. 6 
editorjaconline@gmail.com, www.cirjac.com 
 
    ISSN 2321-807X 
3636 | P a g e                                                             M a y  0 5 , 2 0 1 5  
Introduction 
There are many biologically active bicyclic nucleus containing two heteroatoms. Benzothiazole (I) is used as a chemical 
intermediate in many organic synthesis. It is a component of cyanine dyes and a precursor of rubber accelerators. It is 
also used as a flavoring substance
(1)
.
 
 
Benzothiazole derivatives are interesting compounds and their chemistry has received considerable attention 
(2&3) 
. 
Several derivatives are reported to have useful pharmacological effects, such as antimicrobial,
(4-6) 
anti-inflammatory,
(7&8)
& 
antitumor.
(9&10)
 
         Pyranopyrazole (II) is fused heterocyclic comprised of pyran& pyrazole rings as an important scaffold which plays a 
significant role in pharmaceutical field & biologically active compounds.
(11&12) 
 
       
Compounds bearing pyranopyrazole system have been found to have many biological activities, which includes, 
antimicrobial,
(13) 
antifungal,
(14) 
anti-inflammatory,
(15)
 analgesic,
(16)
 anticancer,
(17) 
& inhibitors of human Chk1 kinase.
(18) 
 
Furthermore, some of these derivatives are commonly in employment like cosmetics & pigments.
(19) 
 These high profile applications and biological significance of benzothiazole and pyranopyrazole containing compounds 
and the speedy development of bacterial resistant to conventional antibiotics
(20)
 impelled us to continue working on the 
synthesis of new analogues of 1,4-dihydropyrano[2,3-c] pyrazole-5- carbonitrile and preliminary pharmacological 
evaluated as an antimicrobial agents.     
EXPERIMENTAL 
Materials and Instruments: Melting points were determined by usingGallenkampelectrical melting 
pointapparatus and are uncorrected. Materials and reagents were obtained from commercial suppliers (Merck grade) and 
were used without further purification. IR spectra were recorded in KBr discs on a Bruker analyzer. 
1
H- NMR spectra were 
recorded on a Bruker (400 MHz) spectrometer, (chemical shifts in δ, ppm) in DMSO-d6 using TMS as internal standard. 
The progress of the reaction was monitored by TLC using Silica Gel G (Merck). 
2-hydrazino-1,3-benzothiazole (1)(21) 
A mixture of 2-mercaptobenzothiazole (29.9 mmole, 5g) and hydrazine hydrate (29.9 mmole, 1.497g) was added and 
mixed thoroughly. The mixture was air dried and subjected to microwave irradiation for 1 minute (completion of reaction as 
indicated by TLC). The reaction mixture was cooled to room temperature and the separated solid was extracted with 
ethanol on standing the filtrated afforded colorless crystalline solid. The product was recrystallized from ethanol, 
C7H7N3S,yield 89%. m.p 202-204
0 
C. 
1-(benzo[d]thiazol-2-yl)-3-methyl-1H-pyrazol-5(4H)-one(2)(22) 
Method a : β- ketoester (5mmole, 0.655g ) was added drop wise to corresponding 2- hydrazinobenzothiazole(5 
mmole,0.825g), the mixture was irradiated with microwave (300 W)  for 10min, the cold reaction mixture was treated with 
ethanol. The solid product was filtered; dried and recrystallized. 
Method b:  Solution of 2- hydrazinobenzothiazole (5 mmole, 0.825g) in ethanol (1ml) was added drop wise to the 
corresponding β- keto ester (5 mmole, 0.655g) contained in a 25ml conical flask. The mixture was irradiated in the water 
bath of an ultrasonic cleaner for 25min.The cold reaction mixture was treated with ethanol. The solid product was filtered 
and dried. 
1-(benzo[d]thiazol-2-yl)-3-methyl-1H-pyrazol-5(4H)-one(2): C11H9N3OS, orange powder; yield 
90.13%; mp.150-152 
0
C; IR (KBr, cm
_1
):  3113 ν(C-H , aromatic),2962,2895 ν(C-H , aliphatic), 2839 ν(CH3) ,1737 ν(CO, 
ester), 1637 ν (C=N),  1595, 1496 ν(C=C), 1246 ν(C-N), 1076,1033,665 ν(C-S-C) ;
1
H-NMR (DMSO-d6, 400 MHz) δ: 2.007 
(3H, s, CH3),  2.238 (2H, s, CH2), 7.266- 7.413 (2H ,d,Ar-H), 7.677 (2H ,d,Ar-H) 
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 Typical procedure for the synthesis of6-amino-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-
3-methyl-1,4,5,6-tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic derivatives  (3a-3f) 
Method a:Introduced(1.3 mmole,0.3 g) of compound (2) in to a clean, dry round bottom flask and dissolved in 
ethanol(4 ml).Then added (1.3 mmole,0.085g) malononitrile, and different aldehyde(1.3 mmole) with constant stirring. The 
reaction mixture was allowed to stir with slow addition of about 3 drops of piperidine and stirring was continued for 2 hrs. 
The solid thus separated was filtered off, washed with distilled water, driedand recrystallized from methanol. 
Microwave method b (23): 
A mixture of (2) (1.3 mmole, 0.3 g), malononitrile (1.3mmole, 0.085g), substituted aromatic aldehyde (1.3 mmole) and 
sodium acetate (3 mmole, 0.231 g ) in 10ml ethanol vessel. Introduced into microwave vessel, the reaction mixture was 
irradiated by300W for 6-10 min at 130
o
C .the formed solid was filtered, washed with water and recrystallized from ethanol. 
6-amino-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-3-methyl-1,4,5,6-tetrahydropyrano[2,3-
c]pyrazole-5-carbonitrilic (3a):yellow powder; C21H15N5OS;  yield 87.3%; mp.1250C; IR (KBr, cm_1): 3335 
ν(NH2),, 3115 ν(C-H , aromatic), 2960,2897ν(C-H , aliphatic) , 2189  ν (CN ),1600 ν (C=N),   1494 ν(C=C), 1247 ν(C-O-C) 
;
1
H- NMR (DMSO-d6, 400 MHz) δ:  1.646 (3H, s, CH3),  ,3.008 (1H ,s, CH) , 6.899(2H,s,NH2) ,   7.270-7.399 (4H, m, 
benzothiazole ring) ,7.497-7.704  (5H , m, Ar-H). 
6-amino-4-(4-chlorophenyl)-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-3-methyl-1,4,5,6-
tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic (3b) : C21H14CIN5OS;pale brown powder; yield 
79.04 %; mp.126-129
0
C; IR (KBr, cm
_1
) 3385 ν(NH2), 3113 ν(C-H , aromatic), 2960,2895 ν(C-H , aliphatic) , 2227 ν (CN),    
1610 ν (C=N),   1583 ν(C=C), 1244 ν(C-O-C);
1
H- NMR (DMSO-d6, 400 MHz) δ:  1.658 (3H, s, CH3),  3.008 (1H ,s, CH) , 
7.707(2H,s,NH2), 7.327-7.564 (8H , m, Ar-H). 
6-amino-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-4-(4-hydroxyphenyl)-3-methyl-1,4,5,6-
tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic (3c):C21H15N5O2S;  brown powder; yield 
87%;mp.120 
0
C; IR (KBr, cm
_1 
):3405 ν(NH2), 3196 ν(C-H , aromatic), 2949,2897 ν(C-H , aliphatic) , 2207 ν (CN),    1614 
ν (C=N),   1518 ν(C=C), 1247 ν(C-O-C);
1
H NMR (DMSO-d6, 400 MHz) δ:  1.646 (3H, s, CH3),  3.012 (1H ,s, CH) , 
6.741(2H,s,NH2), 7.1757.466 (4H, m, benzothiazole ring) ,7..685-7.872  (4H , m, Ar-H), 8.068(IH,s,OH). 
6-amino-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-4-(4-methoxyphenyl)-3-methyl-1,4,5,6-
tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic (3d): C22H17N5O2S dark brown powder; yield 71.44 %; 
mp.100-102 
0
C; IR (KBr, cm
_1 
):  3405 ν(NH2), 3066 ν(C-H , aromatic), 2935,2897 ν(C-H , aliphatic) ,2202 ν (CN),    1608 
ν (C=N),   1512 ν(C=C), 1253 ν(C-O-C) ;
1
H NMR (DMSO-d6, 400 MHz) δ:  1.645 (3H, s, CH3),  3.013 (1H ,s, CH) ,   3.346 
(3H,s,OCH3) , 8.403 (2H,s,NH2), 6.727-7.012  (4H, m, benzothiazole ring) ,7.497-8.041 (4H , m, Ar-H). 
6-amino-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-4-(4-nitrophenyl)-3-methyl-1,4,5,6-
tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic (3e):C23H20N6OS; dark brown  crystals ; yield 83 
.64%; mp.155
0
C; IR (KBr, cm
_1
):   3333 ν(NH2), 3113 ν(C-H , aromatic), 2960,2897 ν(C-H , aliphatic),  2854 ν(CH3) , 2195 
ν(CN), 1622 ν (C=N),  1600 ν(C=C), 1523,1348 ν(NO2),   
1
H NMR (DMSO-d6, 400 MHz) δ:  1.618 (3H, s, CH3), 3.013 (1H 
,s,CH) , 8.403 (2H,s,NH2), 6.727-7.012  (4H, m, benzothiazole ring) ,7.497-8.041 (4H , m, Ar-H). 
6-amino-1-(3a,7a-dihydrobenzo[d]thiazol-2-yl)-4-(4-dimethylamino)phenyl)-3-methyl-
1,4,5,6-tetrahydropyrano[2,3-c]pyrazole-5-carbonitrilic (3f):C21H14N6O3S; red crystals ; yield 
94.84%; mp.173
0
C; IR (KBr, cm
_1
):3387,3306 ν(NH2), 3173 ν(C-H , aromatic), 2956,2883 ν(C-H , aliphatic),  2820 ν(CH3) 
, 2189 ν(CN), 1645 ν (C=N),  1606 ν(C=C), 1396 ν(N-CH3), 1253 ν(C-O-C) 
1
H NMR (DMSO-d6, 400 MHz) δ:  1.645 (3H, s, 
CH3),  2.201 (1H,t,CH)  ,3.013 (1H ,d, CH) ,   3.124 (6H,s,N(CH3)2) , 8.403 (2H,s,NH2), 6.727-7.012  (4H, m, benzothiazole 
ring) ,7.497-8.041 (4H , m, Ar-H). 
Antimicrobial activity: 
The MIC were determined following the recommendations of the Clinical and Laboratory Standards Institute
(24)
.  
Bacterial strains: 
Four species of bacteria were used in this study, two of them are gram positive (Staphylococcus aureus and streptococcus 
pneumonia), the others are gram negative (Klebsiella pneumonia and pseudomonas aeruginosa), the microorganisms 
were available in the bacterial labs of Department of biology/College of science /AL-mustansiriyah University. The species 
had previously been characterized by VITEK 1. 
The synthesized compounds have been studied for their antimicrobial activity in vitro against four tested bacteria at 
concentrations of 62.5,125,250, and 500μg/ml, the DMSO which used pure, Ciprofloxacin and Ceftriaxone were used as a 
    ISSN 2321-807X 
3638 | P a g e                                                             M a y  0 5 , 2 0 1 5  
reference drug for antibacterial activity. They are clinically activated and maintained on nutrient agar medium for testing 
antibacterial.  
Sensitivity Assay: 
Well diffusion assay was carried out by using bacterial suspension of about (1.5×106 CFU/ml) with turbidity standard 
(number 0.5). This was used to inoculate by swabbing the surface of Mueller Hinton agar (MHA) plates. Excess liquid was 
air-dried under a sterile hood. In each agar plate of tested bacteria five wells were made and (100μl) of each concentration 
was added in it. The plates were incubated at 37 °C for 24 hours. The assessment of antibacterial and activity was based 
on measurement of the diameter of inhibition zone in (mm) formed around the well. 
Results and Discussion 
A simple, straightforward and highly efficient multicomponent one-pot synthesis of a pharmaceutically interesting diverse 
kind of functionalized 2-amino-3-cyano-4H-pyrans annulated heterocycles. The reaction occurs via tandem knoevenagel-
cyclocondensation of aromatic aldehydes, malononitrile, and C-H-activated acidic compounds in ethanol at room 
temperature as shown in this scheme. 
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Scheme: Synthesis of final compounds (3a -3f) 
The FT-IR spectrum of compound (2) clearly shows the disappearance of the band of SH group in starting material (1) 
which is a good indication for successful condensation. The spectrum also shows absorption bands at (1737 cm-1) 
referred to (C=O) stretching vibration of ketone, the spectrum also shows an absorption band at (3319, 3201 cm-1) 
referring to (NHNH2) band Stretching, also an absorption band at (1651 cm-1) due to (C=N) stretching vibration.     
The synthesis of 2-aminopyridine-3-carbonitrile derivatives has been accomplished via one-pot reaction, involving 
condensation of 1-(benzo[d]thiazol-2-yl)-3-methyl-1H-pyrazol-5(4H)-one , several aromatic aldehydes and malononitrile 
in the presence of catalytic amount of piperidineby modified Knoevenagel reaction using microwave irradiation. The 
corresponding reactions proceeded smoothly and in excellent yields (85-95%). 
The FT-IR spectrum of compound (3a-3f), shows absorption band at (2189-2227 cm
-1
) which corresponds to (CN) 
stretching vibration which is a good indication for successful condensation, the spectrum also shows  a band at (1600-
1645 cm
-1
) due to (C=N) stretching vibration, (3306-3405 cm
-1
)) for (NH2) stretching vibration, The success of the reaction 
has been confirmed by disappearance of  the (C=O) absorption band in the compound (2). 
The homogeneous mixture turns to precipitate by the addition of ethanol and led to the isolation of pureproducts in good 
yields. Under similar conditions, aromatic aldehydes bearing electron withdrawing & electron donating groups afford the 
corresponding 2-aminopyridine-3-carbonitrile derivatives in high yields and purity During the work-up of the reaction 
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mixture, first itwas cooled, and then adds ethanol to get precipitate. Filter it, dry and then recrystallize it with ethanol. 
Reaction time, % yield and melting points were depicted;all the products were characterized and confirmed by IR,and 
1
H 
NMR data. 
The results of antibacterial activity exhibited that the species Klebsiella pneumonia was the most effected as displayed in 
the diameter of inhibition zone of all concentrations used in the current study, while pseudomonas aeruginosa was less 
affected in general, illustrated in the following table. 
Table: Antibacterial activity of DMSO, 2-mercaptobenzothiazole, Ciprofloxacin Ceftriaxone and  compounds (Va-f) against 
tested bacteria 
Compound No. Concentration 
(µg/ml) 
Inhibition Zone (mm)  
Staphylococcus 
aureus  
streptococcus 
pneumonia 
Klebsiella 
pneumoniae 
pseudomonas 
aeruginosa  
 
Va 
 
500.0 - - 19 - 
250.0 - 4 21 - 
125.0 11 - 13 - 
62.5 11 19 11 - 
 
Vb 
500.0 16 10 19 - 
250.0 - 4 17 - 
125.0 - - 20 - 
62.5 11 11 14 - 
 
Vc 
500.0 29 16 14 14 
250.0 18 - 13 14 
125.0 17 14 14 13 
62.5 10 12 12 18 
 
Vd 
500.0 17 16 12 - 
250.0 14 10 16 - 
125.0 11 13 16 - 
62.5 - 12 11 - 
 
Ve 
500.0 12 10 10 - 
250.0 - 13 10 - 
125.0 - 10 14 - 
62.5 - 10 13 - 
 
Vf 
500.0 27 11 29 - 
250.0 30 13 30 - 
125.0 32 - 25 - 
62.5 30 - 22 - 
 
Ciprofloxacin 
 
500.0 25 28 30 18 
250.0 25 15 32 23 
125.0 25 15 29 19 
62.5 25 14 24 13 
 
Ceftriaxone 
500.0 32 26 10 20 
250.0 28 19 - 19 
125.0 24 17 10 9 
62.5 28 16 4 14 
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DMSO pure - - - - 
 
The concentration 500 (µg/ml) was the most for killing bacteria, the results also showed that the others concentrations 
were less active against bacteria. 
Conclusion: 
In conclusion I have demonstrated a highly efficient method for the synthesis of novel pyranopyrazole derivatives using 
microwave method, the significant advantages of this procedure are simplicity, low cost and higher yields. These newly 
synthesized compounds were screened for antibacterial activity, and among them nitro containing derivative is the only 
one which exhibited antibacterial activity against pseudomonas aeruginosa and n-dimethyl derivative is the best one 
against Klebsiella pneumonia. 
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